Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orexigen Therapeutics Inc (NASDAQ:OREX)

4.21
Delayed Data
As of 2:05pm ET
 -0.17 / -3.88%
Today’s Change
1.65
Today|||52-Week Range
18.00
+141.95%
Year-to-Date
No recent news for Orexigen Therapeutics Inc.

Today’s Trading

Previous close4.38
Today’s open4.50
Day’s range4.19 - 4.37
Volume172,746
Average volume (3 months)569,688
Market cap$63.9M
Dividend yield--
Data as of 2:05pm ET, 02/21/2017

Growth & Valuation

Earnings growth (last year)-62.50%
Earnings growth (this year)-31.82%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-55.95%
P/E ratioNM
Price/Sales9.22
Price/Book1.91

Competitors

 Today’s
change
Today’s
% change
MEIPMEI Pharma Inc-0.01-0.57%
STDYSteadymed Ltd-0.05-1.56%
EPIXESSA Pharma Inc+0.10+4.48%
NBYNovaBay Pharmaceutic...-0.12-2.97%
Data as of 2:05pm ET, 02/21/2017

Financials

Next reporting dateMarch 15, 2017
EPS forecast (this quarter)-$1.58
Annual revenue (last year)$24.5M
Annual profit (last year)-$68.7M
Net profit margin-280.83%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Narachi
Chief Operating Officer &
Executive Vice President
Thomas R. Cannell
Corporate headquarters
La Jolla, California

Forecasts


Search for Jobs